4/A//SEC Filing
Biota Pharmaceuticals, Inc. 4/A
Accession 0001437749-15-012313
$VXRTCIK 0000072444operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:18 PM ET
Size
5.7 KB
Accession
0001437749-15-012313
Insider Transaction Report
Form 4/AAmended
Fox James
Director
Transactions
- Purchase
Common stock
2015-06-10$2.03/sh+70,000$142,100→ 100,614 total(indirect: Penashe Holdings Pty Ltd.)
Holdings
- 8,700
Common stock
Footnotes (2)
- [F1]Mr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities to the extent of any indirect pecuniary interest in his distributive shares therein.
- [F2]The original Form 4 report filed on June 11, 2015 incorrectly reported the purchase date and price of the purchase and excluded the direct holdings of the reporting person.
Documents
Issuer
Biota Pharmaceuticals, Inc.
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:18 PM ET
- Size
- 5.7 KB